Trastuzumab in the treatment of breast cancer

N Engl J Med. 2005 Oct 20;353(16):1734-6. doi: 10.1056/NEJMe058196.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents / therapeutic use*
  • Breast Neoplasms / drug therapy*
  • Chemotherapy, Adjuvant
  • Disease-Free Survival
  • Female
  • Genes, erbB-2
  • Humans
  • Receptor, ErbB-2* / metabolism
  • Recurrence
  • Trastuzumab

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents
  • Receptor, ErbB-2
  • Trastuzumab